Whole health evaluation of multi-system risk: GLP-1 insights
by
8 8 people viewed this event.
ISPOR will host the webinar “Whole Health Evaluation of Multi-system Risk: GLP-1 Insights,” exploring how whole-health evaluation frameworks can better assess the real-world impact of GLP-1 receptor agonists across clinical, behavioural and social determinants of health. The session will feature experts from Truveta discussing how treatment adherence, access, discontinuation and patient context influence outcomes, with the goal of supporting more comprehensive and equity-informed evaluations of therapeutic value.